CDMO Suven Pharmaceuticals Ltd Q2FY24; 11% rise in Profits 6 months ago Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma… Venus Remedies Ltd Q1FY24; 83% fall in Profits 9 months ago Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged… Sakar Healthcare Ltd Q1FY24; 1% fall in Profits 9 months ago Sakar Healthcare Ltd is engaged in manufacturing of Pharmaceutical formulations in the form of liquid injectables, tablets/ capsules, oral liquid… Sanofi India Ltd Q1FY24; 2% rise in Profits 9 months ago Sanofi India is engaged in Business of Manufacture and sale of pharmaceutical products. Financial Results: Sanofi India Ltd reported Revenues… Suven Pharmaceuticals Ltd Q1FY24; 12% rise in Profits 9 months ago Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma… Windlas Biotech Ltd Q1FY24; 20% rise in Profits 9 months ago Windlas Biotech Ltd is a leading domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). The company manufactures both solid… Sun Pharmaceuticals Ltd Q4FY23 results out, revenue grows by 16% 11 months ago Sun Pharmaceuticals Ltd reported Total revenue for Q4 FY23 of ₹10,931 Crore, up from ₹9,447 Crore year on year depicting… Suven Pharmaceuticals Ltd Q4FY23 results out, net profit grows by 35% 11 months ago Suven Pharma is in the business of Contract development & manufacturing organisation (CDMO), catering to the needs of global Pharma… Suven pharmaceuticals Q3FY23 net profit drops by 33 percent 1 year ago The company has reported total income of INR 366.78 crores during the period ended December 31, 2022 as compared to… Jubilant Pharmova reports dip in its net profit by 97% for Q2FY23 2 years ago Jubilant Pharmova reported total income of INR 1,599.5 crores during the period ended September 30, 2022 as compared to INR… Jubilant Pharmova reports dip in its net profit by 71% for Q1FY23 2 years ago Jubilant Pharmova reported total income of INR 1,452 crores during the period ended June 30, 2022 as compared to INR…